Tackling COVID19 by Exploiting Pre-existing Cross-Reacting Spike-Specific Immunity
Qiang Zeng(Chinese PLA General Hospital), Yang Xu(Shanghai University of Medicine and Health Sciences), Gang Huang(Qingdao University), Yong-zhe Li(Peking Union Medical College Hospital)
Cited by 19
Related Papers
Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers
|PLoS Genetics|2013|376
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China
|Emerging Microbes & Infections|2022|32
CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients
|Aging|2020|30
Associations between air pollutant and pneumonia and asthma requiring hospitalization among children aged under 5 years in Ningbo, 2015–2017
|Frontiers in Public Health|2023|29
Spatiotemporal Pattern and Its Determinants for Newly Reported HIV/AIDS Among Older Adults in Eastern China From 2004 to 2021: Retrospective Analysis Study
|JMIR Public Health and Surveillance|2023|17